Clinical Trial Update: Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluated temozolomide plus radiation with or without cediranib maleate in newly diagnosed glioblastoma and gliosarcoma; results comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Cediranib Maleate (cediranib)
• Radiation therapy
• Temozolomide (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Glioblastoma, Adult Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2016-09-19